Skip to main content

Low genetic diversity of Plasmodium falciparum merozoite surface protein 1 and 2 and multiplicity of infections in western Ethiopia following effective malaria interventions



Genetic diversity of malaria parasites can inform the intensity of transmission and poses a major threat to malaria control and elimination interventions. Characterization of the genetic diversity would provide essential information about the ongoing control efforts. This study aimed to explore allelic polymorphism of merozoite surface protein 1 (msp1) and merozoite surface protein 2 (msp2) to determine the genetic diversity and multiplicity of Plasmodium falciparum infections circulating in high and low transmission sites in western Ethiopia.


Parasite genomic DNA was extracted from a total of 225 dried blood spots collected from confirmed uncomplicated P. falciparum malaria-infected patients in western Ethiopia. Of these, 72.4% (163/225) and 27.6% (62/225) of the samples were collected in high and low transmission areas, respectively. Polymorphic msp1 and msp2 genes were used to explore the genetic diversity and multiplicity of falciparum malaria infections. Genotyping of msp1 was successful in 86.5% (141/163) and 88.7% (55/62) samples collected from high and low transmission areas, respectively. Genotyping of msp2 was carried out among 85.3% (139/163) and 96.8% (60/62) of the samples collected in high and low transmission sites, respectively. Plasmodium falciparum msp1 and msp2 genes were amplified by nested PCR and the PCR products were analysed by QIAxcel ScreenGel Software. A P-value of less or equal to 0.05 was considered significant.


High prevalence of falciparum malaria was identified in children less than 15 years as compared with those  ≥ 15 years old (AOR = 2.438, P = 0.005). The three allelic families of msp1 (K1, MAD20, and RO33) and the two allelic families of msp2 (FC27 and 3D7), were observed in samples collected in high and low transmission areas. However, MAD 20 and FC 27 alleles were the predominant allelic families in both settings. Plasmodium falciparum isolates circulating in western Ethiopia had low genetic diversity and mean MOI. No difference in mean MOI between high transmission sites (mean MOI 1.104) compared with low transmission area (mean MOI 1.08) (p > 0.05). The expected heterozygosity of msp1 was slightly higher in isolates collected from high transmission sites (He = 0.17) than in those isolates from low transmission (He = 0.12). However, the heterozygosity of msp2 was not different in both settings (Pfmsp2: 0.04 in high transmission; pfmsp2: 0.03 in low transmission).


Plasmodium falciparum from clinical malaria cases in western Ethiopia has low genetic diversity and multiplicity of infection irrespective of the intensity of transmission at the site of sampling. These may be signaling the effectiveness of malaria control strategies in Ethiopia; although further studies are required to determine how specific intervention strategies and other parameters that drive the pattern.


Malaria remains a global public health problem with 229 million cases and 409,000 deaths globally in 2019. Plasmodium falciparum remains the most dangerous malaria parasite species to humans with important public health consequences mostly in Africa [1].

Multiple Plasmodium strains (also known as multiplicity of infection, MOI) are common in malaria-endemic areas, which may result from the bite of mosquitoes infected with more than one clone or from multiple bites [2]. Interaction and competition of different strains for resources within a host during their life cycles may be important for survival and promotes diversity of the parasite [3, 4]. The presence of multiple infecting strains may also affect key phenotypic traits, including drug resistance [5, 6] and risk of severe disease [7, 8]. Characterizing the genetic diversity of malaria in infected individuals and populations of different endemic settings could help determine the effectiveness of malaria interventions. A multiplicity of the parasite has been proposed as a marker to measure changes in transmission intensity in time and space [9, 10].

Malaria parasites genomic epidemiology studies have been assessed using MOI and the proportion of polyclonal infections (also termed ‘multiple clone infections’ [9, 11]. It is generally assumed that MOI is higher in high transmission settings, while in low transmission settings, most individuals might carry single clone infections. A correlation between transmission intensity and MOI has been reported [12,13,14]. In a study done in Eswatini showed an absence of association between a multiplicity of infection and transmission intensity, most likely due to infections being imported [15]. In Ethiopia, altitude, and climate (rainfall and temperature) are the most significant determinants of malaria transmission. Plasmodium falciparum is the dominant malaria parasite, accounting for 60–70% of all malaria cases [16]. Over the last two decades, malaria morbidity and mortality have been reduced dramatically in the country following intensive use of insecticide residual spray, long-lasting insecticide-treated nets, chemotherapies, improved diagnosis, and case management recent years [17]. Towards local strategies for malaria elimination; it is important to assess the genetic diversity of malaria parasites in different settings to determine the effectiveness of the ongoing interventions and to better understand the parasite population circulating in a given geographic area. In this study, we focus on Western Ethiopia, where there is relatively limited information about the genetic diversity and MOI of P. falciparum. This study aimed to compare the genetic diversity of P. falciparum isolates collected from high and low transmission sites, in western Ethiopia.


Study site and period

This study was carried out during the high malaria transmission season from September to December 2020 in four health centres located in areas with different levels of malaria transmission in the western part of Ethiopia. Western Ethiopia contains the regions of Gambela, Benishangul-Gumuz, and the western zones of Oromia. This study was conducted in two regions; Benishangul-Gumuz and Oromia. Sherkole and Kumurc districts from Benishangul-Gumaz and Gida Ayana district from the Oromia regions were selected to include four health centres for data collection (Fig. 1).

Fig. 1
figure 1

Study area map, Gida Ayana, Sherkole, and Kurmuk districts, Western Ethiopia

Inhabitants in Sherkole and kurmuc districts are 35,954 and 24,345, respectively. Similarly, the population size of the Gida Ayana district is 151,290. In the study districts; Sherkole (P. falciparum = 12, 284 and P. vivax = 74); Kurmuc (P. falciparum = 3788 and P. vivax = 72) and Gida Ayana (P. falciparum = 513, P. vivax = 167 and mixed infection of both species = 5) confirmed malaria cases were reported in 2019/2020.

Sherkole and Horazhab health centres are found in the Assosa zone in the Benishangul-Gumuz Region of Ethiopia. Both health centres are located in areas along the western borders of Sudan which has been characterized by the highest transmission intensity [18]. Malaria transmission remains generally high in the western Ethiopian border area near Sudan [19]. Sherkole health centre is located in the Sherkole district which is bordered by Sudan in the north. Sherkole town is about 754 km from Addis Ababa. Horazhab health centre is located in Kurmuk district, and it is bordered by Sudan in the north and west. It is about 769 km from Addis Ababa.

Anger Gute and Warabo health centres are found in Anger Gute town, Gida Ayana district, East Wollega Zone, the Oromia Regional State. Anger Gute town is 360 km away from Addis Ababa. The altitude of the area is between 1200 and 1500 m above sea level.

Malaria transmission in the Anger Gute area is low and stable. Plasmodium falciparum infection prevalence among children 2–10 years was  < 5% [18]. Incidence of malaria in and around Anger Gute town was 3.43 per 1000 population at risk of the disease and the malaria trend from 2014 to 2018 indicated nearly unchanged numbers of malaria cases [20].

Study design

A health facility-based a cross-sectional study was conducted from September to December 2020. Consenting febrile patients seeking malaria diagnosis at the study sites were recruited.

Sample size

The sample size was determined using a single population formula, using a 13.1% prevalence of malaria in Benishangul-Gumuz regional state [16], a 95% confidence level, and 5% precision. Accordingly, the calculated sample size was 175. With a13% adjustment for non-response rate, a total of 198 uncomplicated falciparum malaria patients were included in the study. The number of patients included from high and low transmission sites was proportional to the number of confirmed P. falciparum reported from the study health facilities in 2019 G.C. Accordingly, from a total of 230 samples, 112, 67, and 51 were collected from Sherkole, Gida Ayana and Kurmuc districts, respectively.

Study population

At each health centre, consenting patients with uncomplicated malaria whose age was greater than 6 months, and microscopically confirmed to be infected with P. falciparum, were enrolled. For confirmatory diagnosis of P. falciparum, finger-prick blood samples were used for thick and thin blood films for slide microscopy were made. Each slide was stained with 10% Giemsa for 10 min and 100 fields examined before designating a sample negative [21]. Once the patients were microscopically confirmed of P. falciparum infection, they were consented to give finger-prick blood samples to prepare dried blood spots (DBS) on filter paper (Whatman No. 1001 320, International Ltd. Maidstone, England). The DBS were kept in plastic bags with desiccants until molecular analysis. Patients with mixed infections with other Plasmodium species were excluded from the study.

Molecular genotyping

Molecular detection of parasite genomic DNA was done at Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine. DNA extraction was done from DBS using the Chelex protocol as earlier described [22] Plasmodium falciparum detection was performed by var gene acidic terminal sequence (varATS) real-time PCR as previously described [23]. For genetic diversity, the genomic DNA of the parasite was amplified by multiplex primary and nested PCR using allele-specific Primers of msp1 and msp2 as per published protocol [24].

There was one set of primers for the primary PCR (pPCR), which was generic for all 3 allelic families of msp1, and 3 sets of primers for the nested PCR (nPCR) that were specific for the allelic families K1, Mad20,and R033 (Table 1). Fluorochrome-labeled forward primers were used for the nPCR to distinguish between the allelic families. Genotypes are distinguished by their fluorescent dye (indicating the allelic family) and by the amplicon size, which was determined by QIAxcel ScreenGel Software, developed for use with the QIAxcel Advanced system.

Table 1 Primers, Thermal cycling conditions of the PCR and controls for msp1 and msp2

There was one set of primers for the pPCR, which was generic for the two allelic families of msp2, and three primers for the nPCR: one reverse primer that was common for both allelic families and two forward primers that were specific for the allelic families 3D7 and Fc27. Fluorochrome-labelled forward primers are used for the nPCR to distinguish between the allelic families. Genotypes were distinguished by their fluorescent dye (indicating the allelic family) and by the amplicon size which was determined by QIAxcel ScreenGel Software, developed for use with the QIAxcel Advanced system.

Data analysis

PCR amplicon bands for msp1 and msp2 were sized and binned using the QIAxcel ScreenGel Software. SPSS 20.0 statistical software package (SPSS, Inc, Chicago, USA) was used for statistical analysis. The allelic frequency of msp1 or msp2 was determined by counting the number of samples observed with a particular allelic variant, divided by the total number of allelic variants observed in all the samples analysed for msp1 or msp2.

An infection with a single allele for both targets was considered as a monoclonal infection and those infections with more than one PCR amplicon for either or both targets were considered polyclonal. Mean MOI in both settings of malaria transmission was determined as the ratio of the total number of amplified bands detected in msp1 and msp2 by the number of samples positive for msp1 and msp2. Frequencies of msp1 or msp2 alleles among the study sites were analysed using the chi-square test. Binary logistic regression analysis was done to determine factors associated with the prevalence and multiplicity of P. falciparum infection. In addition, the student’s t-test was used to compare the mean MOI of both loci between high and low transmission sites.

Expected heterozygosity (HE), a measure of genetic diversity, was calculated by using the following formula: HE = [n/(n − 1)][(1 − Σpi2)], where n is the number of isolates sampled and pi is the allele frequency at a given locus. A p-value of less or equal to 0.05 was considered suggestive of a statistically significant difference between sites.

Ethical considerations

Ethical clearance was obtained from the Ethiopian National Ethics Review Committee and Addis Ababa University, Aklilu Lemma Institute of Pathobiology, IRB. Permission to conduct the study at the health facilities was sought from the relevant regional and district health authorities. Written informed consent was obtained from adult study participants and a parent or guardian of a child. Written informed assent was also taken from children.


Out of 230 microscopically confirmed P. falciparum cases enrolled in the study, 225 of them tested positive by PCR. 72.4% (163/225) and 27.6% (62/225) PCR positive samples were collected from high and low malaria transmission sites, respectively. The mean age of study participants was 17.8 ± 12.7 years and with an age range of 7 months–75 years old. The ratio of males to females was 1.27: 1. The prevalence of falciparum malaria was higher in children less than 15 years as compared with those  ≥ 15 years old (AOR = 2.438, P = 0.005). No significant difference in P. falciparum infections in gender was observed (p > 0.05), (Table 2).

Table 2 Sociodemographic characteristics and occurrence of malaria in western Ethiopia

Genetic polymorphism of msp1 and msp2 genes

Msp1 genotyping was successful in 87% (141/163) and 88.7% (55/62) of samples collected from high and low transmission areas, respectively. Similarly, for msp2 genotyping, 85.3% (139/163) and 96.8% (60/62) samples were successfully genotyped from high and low transmission sites, respectively. The three allelic families of msp1 (K1, MAD20, and RO33) and FC27 and 3D7 of msp2 allelic families were identified in all study sites. There was no difference in the frequency of msp1 or msp2 allelic families by study sites (P > 0.05) (Table 3).

Table 3 Allelic frequency of msp1 and msp2 genotypes in study areas

For msp1, the MAD20 allele was dominant; with a total of 87.2% (123/141), 25.5% (36/141), and 5% (7/141) of the samples from high transmission sites had MAD20, K1, and RO33 allelic families of msp1, respectively. Similarly, 92.7% (51/55), 14.5% (8/55), and 5.45% (3/55) samples collected from low malaria transmission settings had MAD20, K1, and RO33 msp1 allelic families, respectively. Multiclonal infections with K1 + MAD20, and MAD20 + R033 combinations were also observed. In the high transmission setting, K1 + MAD20 accounted for 14.9% (21/141) while the frequency of this allelic combination was 10.9%(6/55) in the low transmission setting (Fig. 2). Allelic combinations of K1 and RO33, and K1/MAD20/RO33 were not detected in any infection.

Fig. 2
figure 2

Distribution of msp1 allele types among P. falciparum isolates in different levels of malaria transmission, western Ethiopia. HMT high malaria transmission, LMT low malaria transmission

The fragment size of MAD 20 alleles observed in high malaria transmission area (103–308 bp) was similar to that seen in P. falciparum isolates from low malaria transmission site (103–295 bp). A similar pattern was also observed with the K1 alleles, where sizes in high malaria transmission ranged from 167 to 282 bp while those from low malaria transmission sites ranged from 167 to 269 bp. In addition, a similar pattern was observed in RO33 where P. falciparum isolates in high and low malaria transmission areas had fragment sizes of (160–162 bp) and (164–165 bp), respectively.

Both FC27 and 3D7 msp2 allelic types identified among the samples collected from both study sites. However; FC27 was the frequent allelic type in western Ethiopia. There was no difference in the frequency of this allele in high transmission 97.8% (136/139) and low transmission 98.3% (159/160) areas. Few multi-allelic infections combining 3D7 + FC27 families were detected (Fig. 3). FC27 fragment size ranging from (159–787 bp) and (144–488 bp) were identified among the isolates collected from high and low malaria transmission study sites, respectively. Similar pattern was also observed with the 3D7 alleles, where sizes in high malaria transmission areas ranged from 270 to 285 bp while those from low malaria transmission ranged from 276 to 288 bp.

Fig. 3
figure 3

Distribution of msp2 Allelo types by the intensity of malaria transmission in western Ethiopia

In western Ethiopia, monoclonal P. falciparum infections were predominant, representing 82.3% (116/141) and 87.3% (48/55) of the samples genotyped for msp1 in high and low transmission sites, respectively. Similarly, 97.2% (135/139) and 96.7% (58/60) of isolates from high and low transmission areas were monoclonal msp2, respectively. No significant difference was observed in the proportion of msp1 or msp2 multiplicity of infection with sex, and age group of study participants and intensity of transmission (P > 0.05) (Table 4).

Table 4 Proportion of multiplicity of P. falciparum infection in relation to sociodemographic indices of patients and level of malaria transmission, western Ethiopia

Plasmodium falciparum isolates collected from western Ethiopia had low mean MOI and there was no significant difference in mean MOI between high transmission (mean MOI = 1.104) and low transmission (mean MOI = 1.08) (p > 0.05). The expected heterozygosity of the msp1 gene was slightly higher in high malaria intensity sites (He = 0.17) than isolates from low malaria intensity (He = 0.12). On the other hand, heterozygosity of the msp2 gene was not different in both settings (Pfmsp2: 0.04; pfmsp2: 0.03), (Table 5).

Table 5 MOI and heterozygosity of msp1 and msp2 of P. falciparum in western Ethiopia


Measuring the complexity of infection and genetic diversity of parasite populations across different endemicities may be used as an indicator to evaluate the efficacy of ongoing control and elimination strategies. While a few studies have investigated MOI and genetic diversity of the P. falciparum population circulating in western Ethiopia, these didn’t represent populations with relatively high and low transmission sites as presented here. The prevalence of uncomplicated falciparum malaria in the populations studied was higher in children  ≤ 15 years than those  ≥ 15 years old (AOR = 2.438, P = 0.005) and this was in agreement with previous reports from Ethiopia and Kenya [25, 26]. Immunity to malaria by an individual depends on their age, the number of infectious mosquito bites [27], and the intensity of transmission [28, 29]. In high transmission areas, the burden of malaria is mainly among young children unlike in areas with low transmission, where the population has the low exposure to infection and malaria occurs in all age groups [25, 30, 31].

The three allelic families of msp1 (K1, MAD20, and RO33) and FC27 and 3D7 of msp2 allelic families were identified in the study areas. However, MAD 20 of msp1 and FC27 of msp2 allelic families were the predominant alleles in both areas with variable malaria endemicity. There was no difference in the frequency of msp1 or msp2 allelic families by the intensity of transmission. Therefore, the population composition of P. falciparum isolates in western Ethiopia shows monoclonality infections regardless of the difference in intensity of transmission intensity and geographic separation of the parasites. This finding suggests the likely presence of a high level of inbreeding among the circulating clones between the study sites. Previous reports had also indicated that malaria parasites in Ethiopia have moderate levels of genetic diversity and a similar population structure of the parasite [32]. They presented the lowest levels of heterozygosity in a continent-wide P. falciparum genomic analysis [33], indicating the need to further determine how they have evolved and are responding to the general interventions recommended for all malaria populations.

The predominance of the MAD 20 for msp1 and the FC27 allelic family for msp2 among P. falciparum isolates was consistent with previous studies done in countries; Myanmar [34], Vietnam  [35], Indonesia [36], that showed MAD 20 predominance and Pakistan [37, 38], and Malaysia [39] that reported FC27 of msp2 dominance; The predominance of the MAD 20 for msp1 and the FC27 allelic family for msp2 were reported in other parts of Africa; North Central Nigeria [40], Equatorial Guinea [41], and Northwest Ethiopia [42]. Although this corroborates previous studies from Ethiopia finding similar patterns with the predominance of MAD 20 [43] and FC27 [44, 45]. Predominance of MAD 20 of msp1 and 3D7/IC1 of msp2 in other reports had shown the predominance of K1 of msp1 and 3D7/IC1 of msp2 in southwestern Ethiopia [46]. This is either due to variance between populations or changes that may have occurred over time following selection by pressure from interventions and reducing transmission intensity.

Most of the participants had monoclonal infections at both msp1 and msp2 loci in both settings. As with previous reports, the multiplicity of infection (MOI) was also not associated with age groups [40, 44]. This was in contrast to other studies that found a correlation between polyclonal infections with age groups [47], though this was in a high transmission region in Burkina-Faso in West Africa. MOI was not associated with the sex of the patients as reported from Burkina Faso[47]. Overall, P. falciparum isolates from Western Ethiopia showed low mean MOI and limited genetic diversity, with no differences based on the intensity of transmission, a pattern that has been seen in some malaria-endemic regions of Africa, the prevalence of infections have generally become low and imported cases are common [15, 48, 49]. Examples of these include Senegal and Eswatini, which are now heading towards pre-elimination. Though high MOI and genetic diversity have been associated with higher malaria-endemicity, these indices as determined by msp1 and msp2 typing may not be sensitive enough at a lower overall transmission level as seen in Ethiopia [12, 41, 50, 51]. However, the lack of differences with the relative variance in transmission intensities might be an indication that malaria control measures that reduce entomological inoculation rate [52, 53], and deployment of artemisinin-combination therapy that reduce population diversity by removing the drug-sensitive parasites [54] have been effective in Ethiopia. It is also possible differences in human demography, ecology, and Anopheles mosquito vector might be shaping P. falciparum population structure in malaria- endemic sites [55,56,57]. Within-host competitive interactions of P. falciparum may also determine the diversity of the parasite [3]. Malaria transmission in Ethiopia is driven mainly by Anopheles arabiensis, while Anopheles pharoensis, Anopheles funestus and Anopheles nili are secondary vectors [58, 59], unlike the situation across the most endemic regions of west and central Africa, where Anopheles gambiae is mostly seen.


Plasmodium falciparum isolates were mainly monoclonal with low MOI and lesser genetic diversity. Mean MOI and diversity of the parasite were not associated with the intensity of malaria transmission. Hence, MOI and the genetic diversity of P. falciparum might not be a good predictor of transmission intensity in all malaria- endemic areas. There is a need to find out an inclusive measurement of the intensity of transmission in all malaria-endemic areas. The observation of low genetic diversity and MOI in the study area may signal the effectiveness of the recent deployment of massive malaria control strategies in Ethiopia; however, this needs further studies to map the different intervention strategies and other parameters that could affect parasite genetic diversity.

Availability of data and materials

The datasets and analysed results of the study are available from the corresponding author and can be obtained on reasonable request.



Dried blood spots


Institute Review Board


Polymerase chain reaction

varATS :

Var gene acidic terminal sequence


Multiplicity of infection

msp1 :

Merozoite surface protein 1

msp2 :

Merozoite surface protein


  1. WHO. Global report on antimalarial drug efficacy and drug resistance: 2000–2010. Geneva: World Health Organization; 2020.

    Google Scholar 

  2. Nkhoma SC, Trevino SG, Gorena KM, Nair S, Khoswe S, Jett C, et al. Co-transmission of related malaria parasite lineages shapes within-host parasite diversity. Cell Host and Microbe. 2020;27:93-103.e4.

    Article  CAS  Google Scholar 

  3. Bashey F. Within-host competitive interactions as a mechanism for the maintenance of parasite diversity. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140301.

    Article  Google Scholar 

  4. He Q, Pilosof S, Tiedje KE, Day KP, Pascual M. Frequency-dependent competition between strains imparts persistence to perturbations in a model of Plasmodium falciparum malaria transmission. Front Ecol Evol. 2021;9:633263.

    Article  Google Scholar 

  5. Bushman M, Morton L, Duah N, Quashie N, Abuaku B, Koram KA, et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proc Biol Sci. 2016;283:20153038.

    Google Scholar 

  6. Kyabayinze DJ, Karamagi C, Kiggundu M, Kamya MR, Wabwire-Mangen F, Kironde F, et al. Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children. Afr Health Sci. 2008;8:200–5.

    Google Scholar 

  7. Sondo P, Derra K, Lefevre T, Diallo-Nakanabo S, Tarnagda Z, Zampa O, et al. Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans. Sci Rep. 2019;9:127.

    Article  Google Scholar 

  8. Kiwuwa MS, Ribacke U, Moll K, Byarugaba J, Lundblom K, Färnert A, et al. Genetic diversity of Plasmodium falciparum infections in mild and severe malaria of children from Kampala. Uganda Parasitol Res. 2013;112:1691–700.

    Article  Google Scholar 

  9. Tusting LS, Bousema T, Smith DL, Drakeley C. Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. Adv Parasitol. 2014;84:151–208.

    Article  Google Scholar 

  10. Lopez L, Koepfli C. Systematic review of Plasmodium falciparum and Plasmodium vivax polyclonal infections: Impact of prevalence, study population characteristics, and laboratory procedures. PLoS ONE. 2021;16:e0249382.

    Article  CAS  Google Scholar 

  11. Zhong D, Koepfli C, Cui L, Yan G. Molecular approaches to determine the multiplicity ofPlasmodium infections. Malar J. 2018;17:172.

    Article  Google Scholar 

  12. Fola AA, Harrison GA, Hazairin MH, Barnadas Cl, Hetzel MW, Iga J, et al. Higher complexity of infection and genetic diversity of Plasmodium vivax than Plasmodium falciparum across all malaria transmission zones of Papua New Guinea. Am J Trop Med Hyg. 2017;96:630.

    Google Scholar 

  13. Funwei RI, Thomas BN, Falade CO, Ojurongbe O. Extensive diversity in the allelic frequency of Plasmodium falciparum merozoite surface proteins and glutamate-rich protein in rural and urban settings of southwestern Nigeria. Malar J. 2018;17:1.

    Article  Google Scholar 

  14. Touray AO, Mobegi VA, Wamunyokoli F, Herren JK. Diversity and multiplicity of P. falciparum infections among asymptomatic school children in Mbita, Western Kenya. Sci Rep. 2020;10:5924.

    Article  CAS  Google Scholar 

  15. Roh ME, Tessema SK, Murphy M, Nhlabathi N, Mkhonta N, Vilakati S, et al. High genetic diversity of Plasmodium falciparum in the low-transmission setting of the Kingdom of Eswatini. J Infect Dis. 2019;220:1346–54.

    Article  Google Scholar 

  16. Assefa A. The third Ethiopian Malaria Indicator Survey 2015 (EMIS-2015). 28th Annual conference.

  17. Bugssa G, Tedla K. Feasibility of malaria elimination in Ethiopia. Ethiop J Health Sci. 2020;30:607–14.

    Google Scholar 

  18. Taffese HS, Jima D, Worku B, Ejigu HK, Balkew M, Mitto B, et al. An epidemiological profile of malaria in Ethiopia. Federal Democratic Republic of Ethiopia, Ministry of Health, Addis Ababa. 2014. Accessed 15 May 2021.

  19. Taffese HS, Hemming-Schroeder E, Koepfli C, Tesfaye G, Lee M-C, Kazura J, et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect Dis Poverty. 2018;7:103.

    Article  Google Scholar 

  20. Dufera M, Kenea O, Tadele G. Malaria incidence and associated risk factors in and around Anger Gute Town Western Ethiopia. Res Sq. 2020.

    Article  Google Scholar 

  21. WHO. Basic malaria microscopy Part I. Learner’s guide. Geneva: World Health Organization; 2010.

    Google Scholar 

  22. Simon N, Shallat J, Williams Wietzikoski C, Harrington WE. Optimization of Chelex 100 resin-based extraction of genomic DNA from dried blood spots. Biol Methods Protoc. 2020;5:bpaa009.

    Article  Google Scholar 

  23. Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788.

    Article  Google Scholar 

  24. Foley M, Ranford-Cartwright LC, Babiker HA. Rapid and simple method for isolating Malaria DNA from fingerprick samples of blood. Mol Biochem Parasitol. 1992;53:241–4.

    Article  CAS  Google Scholar 

  25. Kamau A, Mtanje G, Mataza C, Mwambingu G, Mturi N, Mohammed S, et al. Malaria infection, disease and mortality among children and adults on the coast of Kenya. Malar J. 2020;19:210.

    Article  Google Scholar 

  26. Tegegne Y, Worede A, Derso A, Ambachew S. The prevalence of malaria among children in Ethiopia: a systematic review and meta-analysis. J Parasitol Res. 2021;2021:6697294.

    Article  Google Scholar 

  27. White M, Watson J. Malaria: age, exposure and immunity. Elife. 2018;7:e40150.

    Article  Google Scholar 

  28. Trape J-F, Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today. 1996;12:236–40.

    Article  CAS  Google Scholar 

  29. Coulibaly D, Guindo B, Niangaly A, Maiga F, Konate S, Kodio A, et al. A decline and age shift in malaria incidence in rural Mali following implementation of seasonal malaria chemoprevention and indoor residual spraying. Am J Trop Med Hyg. 2021;104:1342–7.

    Article  CAS  Google Scholar 

  30. Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA, et al. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS ONE. 2010;5:e8988.

    Article  Google Scholar 

  31. Kleinschmidt I, Sharp B. Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity. Trop Med Int Health. 2001;6:986–91.

    Article  CAS  Google Scholar 

  32. Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, et al. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes. PLoS Negl Trop Dis. 2017;11:e0005806.

    Article  Google Scholar 

  33. Amambua-Ngwa A, Amenga-Etego L, Kamau E, Amato R, Ghansah A, Golassa L, et al. Major subpopulations of Plasmodium falciparum in sub-Saharan Africa. Science. 2019;365:813–6.

    Article  CAS  Google Scholar 

  34. Lê HG, Kang J-M, Jun H, Lee J, Thaj TL, Myint MK, et al. Changing pattern of the genetic diversities of Plasmodium falciparum merozoite surface protein-1 and merozoite surface protein-2 in Myanmar isolates. Malar J. 2019;18:241.

    Article  Google Scholar 

  35. Van Long B, Allen G, Brauny M, Linh LTK, Pallerla SR, Huyen TTT, et al. Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces. Malar J. 2020;19:458.

    Article  Google Scholar 

  36. Jamil KF, Supargiyono S, Syafruddin D, Pratama N, Silvy S. The genetic polymorphism of merozoite surface protein-1 in Plasmodium falciparum isolates from Aceh province, Indonesia. IOP Conf Ser: Earth Environ Sci. 2018;125:1-6.

    Article  Google Scholar 

  37. Khatoon L, Khan IU, Shah SA, Jan MI, Ullah F, Malik SA. Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Kohat District. Pakistan Braz J Infect Dis. 2012;16:184–7.

    Article  Google Scholar 

  38. Khan SN, Ali R, Khan S, Rooman M, Norin S, Zareen S, et al. Genetic diversity of polymorphic marker merozoite surface protein 1 (msp-1) and 2 (msp-2) genes of Plasmodium falciparum isolates from malaria endemic region of Pakistan. Front Genet. 2021;12:751552.

    Article  Google Scholar 

  39. Atroosh WM, Al-Mekhlafi HM, Mahdy MA, Saif-Ali R, Al-Mekhlafi AM, Surin J. Genetic diversity of Plasmodium falciparum isolates from Pahang, Malaysia based on MSP-1 and MSP-2 genes. Parasit Vectors. 2011;4:233.

    Article  CAS  Google Scholar 

  40. Oyedeji SI, Bassi PU, Oyedeji SA, Ojurongbe O, Awobode HO. Genetic diversity and complexity of Plasmodium falciparum infections in the microenvironment among siblings of the same household in North-Central Nigeria. Malar J. 2020;19:338.

    Article  Google Scholar 

  41. Chen J-T, Li J, Zha G-C, Huang G, Huang Z-X, Xie D-D, et al. Genetic diversity and allele frequencies of Plasmodium falciparum msp1 and msp2 in parasite isolates from Bioko Island. Equatorial Guinea Malar J. 2018;17:458.

    CAS  Google Scholar 

  42. Mohammed H, Kassa M, Mekete K, Assefa A, Taye G, Commons RJ. Genetic diversity of the msp-1, msp-2, and glurp genes of Plasmodium falciparum isolates in Northwest Ethiopia. Malar J. 2018;17:386.

    Article  CAS  Google Scholar 

  43. File T, Chekol T, Solomon G, Dinka H, Golassa L. Detection of high frequency of MAD20 allelic variants of Plasmodium falciparum merozoite surface protein 1 gene from Adama and its surroundings, Oromia. Ethiopia Malar J. 2021;20:385.

    Article  CAS  Google Scholar 

  44. Mohammed H, Hassen K, Assefa A, Mekete K, Tadesse G, Taye G, et al. Genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria based on msp-1 and msp-2 genes in Gublak. North West Ethiopia Malar J. 2019;18:413.

    CAS  Google Scholar 

  45. Abamecha A, El-Abid H, Yilma D, Addisu W, Ibenthal A, Bayih AG, et al. Genetic diversity and genotype multiplicity of Plasmodium falciparum infection in patients with uncomplicated malaria in Chewaka district. Ethiopia Malar J. 2020;19:203.

    Article  CAS  Google Scholar 

  46. Mohammed H, Mindaye T, Belayneh M, Kassa M, Assefa A, Tadesse M, et al. Genetic diversity of Plasmodium falciparum isolates based on MSP-1 and MSP-2 genes from Kolla-Shele area, Arbaminch Zuria District, southwest Ethiopia. Malar J. 2015;14:73.

    Article  Google Scholar 

  47. Sondo P, Derra K, Rouamba T, Diallo SN, Taconet P, Kazienga A, et al. Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso. Parasit Vectors. 2020;13:427.

    Article  CAS  Google Scholar 

  48. Ralinoro F, Rakotomanga TA, Rakotosaona R, Rakoto DAD, Menard D, Jeannoda V, et al. Genetic diversity of Plasmodium falciparum populations in three malaria transmission settings in Madagascar. Malar J. 2021;20:239.

    Article  CAS  Google Scholar 

  49. Niang M, Loucoubar C, Sow A, Diagne MM, Faye O, Faye O, et al. Genetic diversity of Plasmodium falciparum isolates from concurrent malaria and arbovirus co-infections in Kedougou, southeastern Senegal. Malar J. 2016;15:155.

    Article  Google Scholar 

  50. Oboh MA, Ndiaye T, Diongue K, Ndiaye YD, Sy M, Deme AB, et al. Allelic diversity of MSP1 and MSP2 repeat loci correlate with levels of malaria endemicity in Senegal and Nigerian populations. Malar J. 2021;20:38.

    Article  CAS  Google Scholar 

  51. Kateera F, Nsobya SL, Tukwasibwe S, Mens PF, Hakizimana E, Grobusch MP, et al. Malaria case clinical profiles and Plasmodium falciparum parasite genetic diversity: a cross sectional survey at two sites of different malaria transmission intensities in Rwanda. Malar J. 2016;15:237.

    Article  Google Scholar 

  52. Chitnis N, Hardy D, Gnaegi G, Boutsika K, Maire N, Steketee R, et al. Modelling the effects of vector control interventions in reducing malaria transmission, morbidity and mortality. Malar J. 2010;9(Suppl 2):O7.

    Article  Google Scholar 

  53. Shaukat AM, Breman JG, McKenzie FE. Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J. 2010;9:122.

    Article  Google Scholar 

  54. Ndiaye YD, Hartl DL, McGregor D, Badiane A, Fall FB, Daniels RF, et al. Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations. Int J Parasitol Drugs Drug Resist. 2021;17:12–22.

    Article  CAS  Google Scholar 

  55. Annan Z, Durand P, Ayala FJ, Cl Arnathau, Awono-Ambene P, Simard F, et al. Population genetic structure of Plasmodium falciparum in the two main African vectors, Anopheles gambiae and Anopheles funestus. Proc Natl Acad Sci USA. 2007;104:7987–92.

    Article  Google Scholar 

  56. Morlais I, Nsango SE, Toussile W, Abate L, Annan Z, Tchioffo MT, et al. Plasmodium falciparum mating patterns and mosquito infectivity of natural isolates of gametocytes. PLoS ONE. 2015;10:e0123777.

    Article  Google Scholar 

  57. Tagliamonte MS, Yowell CA, Elbadry MA, Boncy J, Raccurt CP, Okech BA, et al. Genetic markers of adaptation of Plasmodium falciparum to transmission by American vectors identified in the genomes of parasites from Haiti and South America. mSphere. 2020;5:e00937-20.

    Article  Google Scholar 

  58. MOH. National malaria guidelines. Addis Ababa, 2012.

  59. The President's Malaria Initiative. Eleventh Annual Report to Congress. Washington, 2017.

Download references


The authors would like to thank all P. falciparum patients for their willingness to participate in the study. We would also like to thank Medical Research Council Unit The Gambia, at the London School of Hygiene and Tropical Medicine, Gambia for the permission to use the molecular biology laboratory and the PAMGEN H3Africa project for financial support.


This work was supported by the PAMGEN H3 Africa project (H3A/002/18) and Addis Ababa University, Post Graduate studies.

Author information

Authors and Affiliations



Conceptualization: Dr. LG and GT. Supervision of the overall work: Dr. LG, Dr. AAN, and Dr. SD. Methodology: GT and Dr. LG. Laboratory work: GT, FKJ, EO and MO. Write up of the original draft of the manuscript: GT. Reviewing and editing the manuscript: Dr. LG, Dr. AAN, Dr. SD, EO, and MO. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Geletta Tadele.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was obtained from the Ethiopian National Ethic review committee, Addis Ababa, Ethiopia (No. MoSHE 04/246/66) and Institutional review board of Aklilu Lemma Institute of Pathobiology, Addis Ababa University (No. ALIPB IRB/ 19/2012/20). Written informed consent was obtained from adult study participants and a parent or guardian of a child. Written informed assent was also taken from children.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tadele, G., Jaiteh, F.K., Oboh, M. et al. Low genetic diversity of Plasmodium falciparum merozoite surface protein 1 and 2 and multiplicity of infections in western Ethiopia following effective malaria interventions. Malar J 21, 383 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • MOI
  • Genetic diversity
  • P. falciparum
  • Malaria transmission
  • Western Ethiopia